These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8633100)

  • 1. Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy.
    Zhang JF; Hu C; Geng Y; Selm J; Klein SB; Orazi A; Taylor MW
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4513-8. PubMed ID: 8633100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and regression.
    Zhang JF; Hu C; Geng Y; Blatt LM; Taylor MW
    Cancer Gene Ther; 1996; 3(1):31-8. PubMed ID: 8785709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice.
    Qin XQ; Tao N; Dergay A; Moy P; Fawell S; Davis A; Wilson JM; Barsoum J
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14411-6. PubMed ID: 9826714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
    Lindner DJ; Borden EC; Kalvakolanu DV
    Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35.
    Pichiorri F; Trapasso F; Palumbo T; Aqeilan RI; Drusco A; Blaser BW; Iliopoulos D; Caligiuri MA; Huebner K; Croce CM
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3494-501. PubMed ID: 16740775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.
    Wills KN; Maneval DC; Menzel P; Harris MP; Sutjipto S; Vaillancourt MT; Huang WM; Johnson DE; Anderson SC; Wen SF
    Hum Gene Ther; 1994 Sep; 5(9):1079-88. PubMed ID: 7833367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting interferon-alpha increases antitumor efficacy and reduces hepatotoxicity of E1A-mutated spread-enhanced oncolytic adenovirus.
    Shashkova EV; Spencer JF; Wold WS; Doronin K
    Mol Ther; 2007 Mar; 15(3):598-607. PubMed ID: 17191072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells.
    He X; Liu J; Yang C; Su C; Zhou C; Zhang Q; Li L; Wu H; Liu X; Wu M; Qian Q
    Hum Gene Ther; 2011 Mar; 22(3):283-92. PubMed ID: 20846024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
    Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW
    Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha.
    Mecchia M; Matarrese P; Malorni W; D'Agostino G; Sestili P; Santini SM; Gauzzi MC; Venditti M; Mazzocchi A; Parmiani G; Belardelli F; Ferrantini M
    Gene Ther; 2000 Jan; 7(2):167-79. PubMed ID: 10673721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.
    Xu HJ; Zhou Y; Seigne J; Perng GS; Mixon M; Zhang C; Li J; Benedict WF; Hu SX
    Cancer Res; 1996 May; 56(10):2245-9. PubMed ID: 8625292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated interferon-gamma transfer inhibits growth of transplanted HTLV-1 Tax tumors in mice.
    Xu X; Dai Y; Heidenreich O; Nerenberg MI
    Hum Gene Ther; 1996 Mar; 7(4):471-7. PubMed ID: 8800741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
    Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M
    J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice.
    Su ZZ; Madireddi MT; Lin JJ; Young CS; Kitada S; Reed JC; Goldstein NI; Fisher PB
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14400-5. PubMed ID: 9826712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
    Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies.
    Grace MJ; Xie L; Musco ML; Cui S; Gurnani M; DiGiacomo R; Chang A; Indelicato S; Syed J; Johnson R; Nielsen LL
    Am J Pathol; 1999 Dec; 155(6):1869-78. PubMed ID: 10595917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma.
    Hoffmann D; Bayer W; Heim A; Potthoff A; Nettelbeck DM; Wildner O
    J Invest Dermatol; 2008 Apr; 128(4):988-98. PubMed ID: 17960177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
    Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
    Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.
    Israyelyan AH; Melancon JM; Lomax LG; Sehgal I; Leuschner C; Kearney MT; Chouljenko VN; Baghian A; Kousoulas KG
    Hum Gene Ther; 2007 May; 18(5):457-73. PubMed ID: 17536976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
    Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA
    Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.